Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic Vaccine
Links shared publicly online about this topic.
- 1,620total visits
Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic Vaccine
Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura®. Novartis continue
View full resource at medicalnewstoday.com
Tags: Vaccination, Flu, H1N1, Vaccine, Novartis
Most Recently Shared on November 7, 2009 at 12:56 pm By:
Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1.. http://bit.ly/2VuoI7 #swine_flu
Also Shared By:
Advertisement
Matthew Browning
@MatthewBrowning
RT @ocdgirl2000: Novartis will make serious cash off H1N1 flu too! Germany has their hands in the cookie jar!Celtura® http://url4.eu/i6Ik
1 year ago...